National Health Investors, Inc. (NYSE:NHI – Get Free Report) has earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $84.8333.
Several research firms have recently weighed in on NHI. Cantor Fitzgerald began coverage on shares of National Health Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $90.00 price objective for the company. Truist Financial raised their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Wedbush upgraded shares of National Health Investors to a “strong-buy” rating in a research report on Wednesday, July 2nd. Weiss Ratings restated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Finally, KeyCorp upgraded shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a research report on Thursday, July 10th.
Check Out Our Latest Analysis on NHI
Institutional Trading of National Health Investors
National Health Investors Stock Performance
Shares of NHI opened at $75.20 on Friday. The firm has a 50-day moving average price of $77.13 and a 200 day moving average price of $74.23. The firm has a market capitalization of $3.57 billion, a PE ratio of 24.03, a P/E/G ratio of 3.39 and a beta of 0.77. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. National Health Investors has a 52-week low of $65.13 and a 52-week high of $82.32.
National Health Investors (NYSE:NHI – Get Free Report) last announced its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analyst estimates of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.18 EPS. On average, sell-side analysts anticipate that National Health Investors will post 4.41 earnings per share for the current fiscal year.
National Health Investors Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This is a positive change from National Health Investors’s previous quarterly dividend of $0.90. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.9%. National Health Investors’s payout ratio is 117.57%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
- Five stocks we like better than National Health Investors
- How to Evaluate a Stock Before BuyingÂ
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- How to Capture the Benefits of Dividend Increases
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
